MBOT insider trading

NasdaqCM Healthcare

Microbot Medical Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
80
Last 90 days
10
Buys / sells
0% / 75%
Market cap
$142.38M

About Microbot Medical Inc.

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Company website: microbotmedical.com

MBOT insider activity at a glance

FilingIQ has scored 80 insider transactions for MBOT since Nov 28, 2016. The most recent filing in our index is dated Apr 1, 2026.

Across the full history, 0 open-market purchases and 60 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MBOT insider trades is 47.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for MBOT?
FilingIQ tracks 80 Form 4 insider transactions for MBOT (Microbot Medical Inc.), covering filings from Nov 28, 2016 onwards. 10 of those were filed in the last 90 days.
Are MBOT insiders net buyers or net sellers?
Across the full Form 4 history for MBOT, 0 transactions (0%) were open-market purchases and 60 (75%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MBOT insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MBOT in?
Microbot Medical Inc. (MBOT) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $142.38M.

Methodology & sources

Every MBOT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.